EXPR Fundamental Analysis - EXPRESS INC

Fundamental Rating

EXPR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 120 industry peers in the Specialty Retail industry. While EXPR is still in line with the averages on profitability rating, there are concerns on its financial health. EXPR is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EXPR has reported negative net income.

In the past year EXPR has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: EXPR reported negative net income in multiple years.

In multiple years EXPR reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of EXPR (12.19%) is better than 88.28% of its industry peers.

The Return On Equity of EXPR (120.91%) is better than 97.66% of its industry peers.

		Industry Rank	Sector Rank
ROA	12.19%
ROE	120.91%
ROIC	N/A

ROA(3y)-2.64%

ROA(5y)-3.25%

ROE(3y)-1730.52%

ROE(5y)-1046.08%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

EXPR has a Profit Margin of 10.01%. This is amongst the best in the industry. EXPR outperforms 92.97% of its industry peers.

EXPR's Profit Margin has improved in the last couple of years.

EXPR has a Gross Margin of 22.40%. This is in the lower half of the industry: EXPR underperforms 76.56% of its industry peers.

In the last couple of years the Gross Margin of EXPR has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	10.01%
GM	22.4%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y78.26%

GM growth 3Y1.31%

GM growth 5Y-0.5%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

EXPR does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for EXPR has been increased compared to 1 year ago.

EXPR has less shares outstanding than it did 5 years ago.

Compared to 1 year ago, EXPR has an improved debt to assets ratio.

2.2 Solvency

EXPR has an Altman-Z score of 0.97. This is a bad value and indicates that EXPR is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.97, EXPR is doing worse than 69.53% of the companies in the same industry.

EXPR has a Debt/Equity ratio of 1.83. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 1.83, EXPR is not doing good in the industry: 67.19% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	1.83
Debt/FCF	N/A
Altman-Z	0.97

ROIC/WACCN/A

WACC15.82%

2.3 Liquidity

EXPR has a Current Ratio of 0.98. This is a bad value and indicates that EXPR is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 0.98, EXPR is doing worse than 86.72% of the companies in the same industry.

EXPR has a Quick Ratio of 0.98. This is a bad value and indicates that EXPR is not financially healthy enough and could expect problems in meeting its short term obligations.

EXPR has a Quick ratio of 0.19. This is amonst the worse of the industry: EXPR underperforms 85.94% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.98
Quick Ratio	0.19

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for EXPR have decreased strongly by -521.75% in the last year.

The Earnings Per Share has been growing by 76.94% on average over the past years. This is a very strong growth

The Revenue has decreased by -8.11% in the past year.

EXPR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.89% yearly.

EPS 1Y (TTM)-521.75%

EPS 3YN/A

EPS 5Y76.94%

EPS Q2Q%29.1%

Revenue 1Y (TTM)-8.11%

Revenue growth 3Y-2.63%

Revenue growth 5Y-2.89%

Sales Q2Q%4.6%

3.2 Future

EXPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.01% yearly.

The Revenue is expected to grow by 2.32% on average over the next years.

EPS Next Y-135.77%

EPS Next 2Y14.55%

EPS Next 3Y16.01%

EPS Next 5YN/A

Revenue Next Year-1.98%

Revenue Next 2Y2.16%

Revenue Next 3Y2.32%

Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXPR. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EXPR. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as EXPR's earnings are expected to grow with 16.01% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y14.55%

EPS Next 3Y16.01%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

EXPR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EXPRESS INC

NYSE:EXPR (3/6/2024, 8:04:00 PM)

2.29

+0.06 (+2.69%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)11-30 2023-11-30/bmo

Earnings (Next)N/A N/A

Inst Owners0%

Inst Owner Change-2.21%

Ins Owners197.99%

Ins Owner Change0%

Market Cap8.59M

Analysts82.86

Price Target20.4 (790.83%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)11.5%

Min EPS beat(2)3.19%

Max EPS beat(2)19.81%

EPS beat(4)3

Avg EPS beat(4)1.52%

Min EPS beat(4)-31.14%

Max EPS beat(4)19.81%

EPS beat(8)6

Avg EPS beat(8)57.46%

EPS beat(12)10

Avg EPS beat(12)110.69%

EPS beat(16)11

Avg EPS beat(16)59.58%

Revenue beat(2)0

Avg Revenue beat(2)-4.35%

Min Revenue beat(2)-5.54%

Max Revenue beat(2)-3.17%

Revenue beat(4)0

Avg Revenue beat(4)-4.56%

Min Revenue beat(4)-6.05%

Max Revenue beat(4)-3.17%

Revenue beat(8)1

Avg Revenue beat(8)-3.63%

Revenue beat(12)3

Avg Revenue beat(12)-2.74%

Revenue beat(16)3

Avg Revenue beat(16)-5.37%

PT rev (1m)21.21%

PT rev (3m)21.21%

EPS NQ rev (1m)-34.22%

EPS NQ rev (3m)-703.11%

EPS NY rev (1m)-7.14%

EPS NY rev (3m)-55.01%

Revenue NQ rev (1m)0.24%

Revenue NQ rev (3m)-4.96%

Revenue NY rev (1m)0.05%

Revenue NY rev (3m)-3.87%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0
P/FCF	N/A
P/OCF	N/A
P/B	0.06
P/tB	0.06
EV/EBITDA	N/A

EPS(TTM)-49.74

EYN/A

EPS(NY)-15.54

Fwd EYN/A

FCF(TTM)-63.72

FCFYN/A

OCF(TTM)-51.35

OCFYN/A

SpS476.52

BVpS39.45

TBVpS39.45

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	12.19%
ROE	120.91%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	10.01%
GM	22.4%
FCFM	N/A

ROA(3y)-2.64%

ROA(5y)-3.25%

ROE(3y)-1730.52%

ROE(5y)-1046.08%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y78.26%

GM growth 3Y1.31%

GM growth 5Y-0.5%

F-Score4

Asset Turnover1.22

Health

		Industry Rank	Sector Rank
Debt/Equity	1.83
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	80.49%
Cap/Sales	2.6%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.98
Quick Ratio	0.19
Altman-Z	0.97

F-Score4

WACC15.82%

ROIC/WACCN/A

Cap/Depr(3y)50.21%

Cap/Depr(5y)50.38%

Cap/Sales(3y)1.93%

Cap/Sales(5y)2%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-521.75%

EPS 3YN/A

EPS 5Y76.94%

EPS Q2Q%29.1%

EPS Next Y-135.77%

EPS Next 2Y14.55%

EPS Next 3Y16.01%

EPS Next 5YN/A

Revenue 1Y (TTM)-8.11%

Revenue growth 3Y-2.63%

Revenue growth 5Y-2.89%

Sales Q2Q%4.6%

Revenue Next Year-1.98%

Revenue Next 2Y2.16%

Revenue Next 3Y2.32%

Revenue Next 5YN/A

EBIT growth 1Y-924.74%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-76.87%

EBIT Next 3Y36.9%

EBIT Next 5YN/A

FCF growth 1Y-1482.48%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-3156.62%

OCF growth 3YN/A

OCF growth 5YN/A

EXPRESS INC (EXPR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens